-

Ancora Issues Statement Regarding Potential Acquirer Interest in Everbridge

Believes Multiple Financial Sponsors Have Interest in Acquiring the Company

Urges Board to Initiate a Review of Strategic Alternatives and Promptly Engage with Interested Suitors

CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group, LLC (together with its affiliates, “Ancora” or “we”), a significant shareholder of Everbridge, Inc. (NASDAQ: EVBG) (“Everbridge” or the “Company”), today issued the below statement as a follow-up to its March 17th letter that urged the Board of Directors (the “Board”) to explore strategic alternatives.

Fredrick D. DiSanto, Chairman and Chief Executive Officer of Ancora, and James Chadwick, President of Ancora Alternatives LLC, commented:

“We believe multiple financial sponsors have interest in pursuing an acquisition of Everbridge. In fact, one financial sponsor told us after seeing our March 17th letter that it informed the Company of its interest before ultimately receiving a tepid response. If this is true, we find the Board’s conduct unacceptable. We urge the Board to immediately initiate a strategic process to evaluate sale opportunities and engage with a broad set of potential buyers. We continue to believe Everbridge is dramatically undervalued at current share price levels, and a sale to a well-capitalized acquirer could deliver more than $70 per share for shareholders based on recent valuation multiples for both public and private company peers as well as recent software transactions.1 We intend to do everything in our power to hold the incumbents accountable if they do not pursue a value-maximizing sale.”

About Ancora

Founded in 2003, Ancora Holdings Group, LLC offers integrated investment advisory, wealth management and retirement plan services to individuals and institutions across the United States. The firm's comprehensive service offering is complemented by a dedicated team that has the breadth of expertise and operational structure of a global institution, with the responsiveness and flexibility of a boutique firm. For more information about Ancora, please visit https://ancora.net.

_____________________________
1 Ancora estimate of more than $70 per share reflects approximately 7.5x EV/Sales.

Contacts

Longacre Square Partners
Greg Marose / Bela Kirpalani, 646-386-0091
gmarose@longacresquare.com / bkirpalani@longacresquare.com

Industry:

Ancora Holdings Group, LLC

Release Versions
English

Contacts

Longacre Square Partners
Greg Marose / Bela Kirpalani, 646-386-0091
gmarose@longacresquare.com / bkirpalani@longacresquare.com

More News From Ancora Holdings Group, LLC

Ancora Reaffirms Offer to Acquire H.B. Fuller’s BAS Segment

CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group LLC (together with its affiliates, “Ancora”), a meaningful shareholder of H.B. Fuller Company (NYSE: FUL) (“H.B. Fuller” or the “Company”), today reaffirmed its proposal to acquire the Company’s Building Adhesive Solutions (“BAS”) segment following H.B. Fuller’s Board of Directors’ (the “Board”) baseless rejection of the offer and issued the following statement: “First and foremost, Ancora reaffirms the offer that it recently submitted, as it is...

Ancora Holdings Group Submits Proposal to Acquire H.B. Fuller’s Building Adhesive Solutions Segment for $1.1 Billion to $1.2 Billion in Cash

CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group LLC (together with its affiliates, “Ancora”), a meaningful shareholder of H.B. Fuller Company (NYSE: FUL) (“H.B. Fuller” or the “Company”), today released the below correspondence sent to the Company’s Board of Directors regarding Ancora’s proposal to acquire H.B. Fuller’s Building Adhesive Solutions (“BAS”) segment for between $1.1 billion and $1.2 billion in cash. The full text of the letter follows: August 12, 2026 H.B. Fuller Company Attn: T...

Ancora Condemns H.B. Fuller’s Decision to Ignore Shareholder Opposition and Proceed with the Reckless Acquisition of Advanced Medical Solutions

CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group, LLC (collectively with its affiliates, “Ancora” or “we”) today released the below statement regarding H.B. Fuller Company (NYSE: FUL) (“H.B. Fuller” or the “Company”) and Advanced Medical Solutions Group plc (“AMS”). Previously, Ancora issued a letter to H.B. Fuller’s Board of Directors (the “Board”) regarding its contemplated acquisition of AMS. Fredrick D. DiSanto, Chairman and Chief Executive Officer of Ancora, and James Chadwick, President...
Back to Newsroom